Skip to main content
    N

    Nexgel Inc (NXGL)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.93
    +0.05 (+1.29%)

    Market Cap: $2.08M

    Last updated: Nov 17, 2026 at 10:58 AM ET

    Nexgel Inc (NXGL) Financials: Revenue, Profit and Cash Flow

    Updated Nov 10, 2026. Financial statements from company filings, amounts in US dollars.

    Nexgel reported revenue of $11.42M for the fiscal year ended Dec 31, 2025, up 31.5% from the year before. That year, net income was -$2.89M with a net margin of -25.3%, operating cash flow was -$1.31M and free cash flow was -$1.38M. The quarter ended Sep 30, 2026 had revenue of $3.18M and net income of -$1.09M.

    Revenue and Margins

    The operating margin was -29.3% in the fiscal year ended Dec 2025, the highest of the 6 years shown with an operating margin. Over the 9 years to Dec 2025, revenue grew from $2.15M, a compound annual rate of 20.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$11.42M+31.5%39.5%-29.3%-25.3%
    Dec 2024$8.69M+112.5%31.6%-40.9%-39.9%
    Dec 2023$4.09M+99.7%9.1%-85.0%-78.0%
    Dec 2022$2.05M+32.0%12.5%-163.5%-231.7%
    Dec 2021$1.55M+130.1%0.5%-165.7%-277.9%
    Dec 2020$674.00K-6.0%-43.2%-335.3%-335.9%
    Dec 2019$717.00K-67.6%-19.1%-268.3%-268.2%
    Dec 2018$2.21M+11.1%23.2%-85.3%-170.6%
    Dec 2017$1.99M-7.4%7.4%-48.6%-47.8%
    Dec 2016$2.15MN/A-5.3%-86.6%-82.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$11.42M$8.69M$4.09M$2.05M$1.55M$674.00K$717.00K$2.21M$1.99M$2.15M
    Cost of revenue$6.91M$5.94M$3.71M$1.79M$1.54M$965.00K$854.00K$1.70M$1.84M$2.27M
    Gross profit$4.51M$2.75M$374.00K$256.00K$8.00K-$291.00K-$137.00K$514.00K$147.00K-$114.00K
    Research and development$2.00K$78.00K$103.00K$367.00K$31.00K$0$0$0$0$0
    Operating income-$3.35M-$3.55M-$3.48M-$3.35M-$2.57M-$2.26M-$1.92M-$1.89M-$969.00K-$1.86M
    Net income-$2.89M-$3.46M-$3.19M-$4.75M-$4.31M-$2.26M-$1.92M-$3.78M-$953.00K-$1.78M
    EBITDA-$2.12M-$2.70M-$2.73M-$1.64M-$284.00K-$2.20M-$1.85M$314.00K-$653.00K-$1.54M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$3.18M$3.69M$2.65M$2.80M$2.93M$2.88M$2.81M$3.04M$2.94M$1.44M$1.27M$1.08M
    Gross profit$1.13M$1.11M$1.06M$820.00K$1.24M$1.26M$1.19M$1.14M$1.16M$293.00K$160.00K-$88.00K
    Operating income-$2.54M-$2.50M-$958.00K-$1.21M-$725.00K-$636.00K-$777.00K-$841.00K-$788.00K-$1.05M-$871.00K-$1.22M
    Net income-$1.09M-$3.61M-$871.00K-$928.00K-$647.00K-$640.00K-$678.00K-$825.00K-$754.00K-$979.00K-$905.00K-$1.19M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $588.00K exceeded cash and equivalents by $271.00K.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$10.46M$10.98M$9.96M$10.36M$16.98M$2.26M$1.89M$739.00K$894.00K$1.26M
    Current assets$4.34M$5.11M$5.05M$7.50M$13.93M$363.00K$513.00K$361.00K$199.00K$257.00K
    Cash and equivalents$317.00K$1.81M$2.70M$1.10M$13.35M$32.00K$261.00K$0N/AN/A
    Total liabilities$5.57M$4.90M$4.79M$2.72M$4.90M$2.19M$1.51M$458.00K$269.00K$467.00K
    Short-term debt$99.00K$97.00K$80.00K$15.00K$2.05M$59.00K$0$0N/AN/A
    Long-term debt$489.00K$588.00K$513.00K$268.00K$266.00K$256.00KN/AN/AN/AN/A
    Shareholder equity$4.46M$5.75M$4.70M$7.64M$12.09M$71.00K$380.00K$281.00K$625.00K$794.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$23.90M$26.45M$11.60M$10.46M$11.62M$9.71M$10.44M$10.98M$10.57M$9.78M$10.38M$9.96M
    Total liabilities$19.23M$20.98M$7.12M$5.57M$6.04M$4.66M$4.87M$4.90M$5.59M$5.25M$5.18M$4.79M
    Cash and equivalents$278.00K$492.00K$208.00K$317.00K$938.00K$725.00K$1.19M$1.81M$1.06M$1.07M$2.42M$2.70M
    Shareholder equity$4.13M$4.95M$3.99M$4.46M$5.19M$4.67M$5.21M$5.75M$4.69M$4.17M$4.79M$4.70M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$1.31M-$3.87M-$3.24M-$2.99M-$2.75M-$1.80M-$1.81M-$1.54M-$777.00K-$1.32M
    Capital expenditures$68.00K$443.00K$696.00K$96.00K$269.00K$312.00K$312.00K$312.00K$7.00K$0
    Free cash flow-$1.38M-$4.31M-$3.93M-$3.09M-$3.02M-$2.11M-$2.13M-$1.86M-$784.00K-$1.32M
    Investing cash flow-$68.00K-$775.00K$4.46M-$5.59M-$269.00K-$312.00K$0$0-$7.00KN/A
    Financing cash flow$630.00K$3.75M$379.00K-$3.66M$16.34M$1.88M$2.08M$1.54M$784.00K$1.32M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.13M-$2.20M-$504.00K$281.00K-$785.00K-$407.00K-$400.00K-$859.00K-$1.22M-$700.00K-$1.09M-$587.00K
    Capital expenditures$32.00K$76.00K$9.00K$40.00K$8.00K$20.00K$0$69.00K$13.00K$209.00K$152.00K$85.00K
    Free cash flow-$1.16M-$2.27M-$513.00K$241.00K-$793.00K-$427.00K-$400.00K-$928.00K-$1.23M-$909.00K-$1.24M-$672.00K
    Last 12 quarters

    Frequently Asked Questions About NXGL

    What is Nexgel's annual revenue?

    Nexgel reported revenue of $11.42M for the fiscal year ended Dec 31, 2025.

    How fast is Nexgel's revenue growing?

    Revenue was up 31.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 77.3%.

    Is Nexgel profitable?

    No. Nexgel reported net income of -$2.89M for the fiscal year ended Dec 31, 2025, with a net margin of -25.3%.

    How much free cash flow does NXGL generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$1.31M minus capital expenditures of $68.00K produced free cash flow of -$1.38M.

    How much debt does Nexgel have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $489.00K, short-term debt of $99.00K and cash and equivalents of $317.00K.